Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/33190
Title: BRAT1-related disorders: phenotypic spectrum and phenotype-genotype correlations from 97 patients.
Austin Authors: Engel, Camille;Valence, Stéphanie;Delplancq, Geoffroy;Maroofian, Reza;Accogli, Andrea;Agolini, Emanuele;Alkuraya, Fowzan S;Baglioni, Valentina;Bagnasco, Irene;Becmeur-Lefebvre, Mathilde;Bertini, Enrico;Borggraefe, Ingo;Brischoux-Boucher, Elise;Bruel, Ange-Line;Brusco, Alfredo;Bubshait, Dalal K;Cabrol, Christelle;Cilio, Maria Roberta;Cornet, Marie-Coralie;Coubes, Christine;Danhaive, Olivier;Delague, Valérie;Denommé-Pichon, Anne-Sophie;Di Giacomo, Marilena Carmela;Doco-Fenzy, Martine;Engels, Hartmut;Cremer, Kirsten;Gérard, Marion;Gleeson, Joseph G;Heron, Delphine;Goffeney, Joanna;Guimier, Anne;Harms, Frederike L;Houlden, Henry;Iacomino, Michele;Kaiyrzhanov, Rauan;Kamien, Benjamin;Karimiani, Ehsan Ghayoor;Kraus, Dror;Kuentz, Paul;Kutsche, Kerstin;Lederer, Damien;Massingham, Lauren;Mignot, Cyril;Morris-Rosendahl, Déborah;Nagarajan, Lakshmi;Odent, Sylvie;Ormières, Clothilde;Partlow, Jennifer Neil;Pasquier, Laurent;Penney, Lynette;Philippe, Christophe;Piccolo, Gianluca;Poulton, Cathryn;Putoux, Audrey;Rio, Marlène;Rougeot, Christelle;Salpietro, Vincenzo;Scheffer, Ingrid E ;Schneider, Amy L ;Srivastava, Siddharth;Straussberg, Rachel;Striano, Pasquale;Valente, Enza Maria;Venot, Perrine;Villard, Laurent;Vitobello, Antonio;Wagner, Johanna;Wagner, Matias;Zaki, Maha S;Zara, Federizo;Lesca, Gaetan;Yassaee, Vahid Reza;Miryounesi, Mohammad;Hashemi-Gorji, Farzad;Beiraghi, Mehran;Ashrafzadeh, Farah;Galehdari, Hamid;Walsh, Christopher;Novelli, Antonio;Tacke, Moritz;Sadykova, Dinara;Maidyrov, Yerdan;Koneev, Kairgali;Shashkin, Chingiz;Capra, Valeria;Zamani, Mina;Van Maldergem, Lionel;Burglen, Lydie;Piard, Juliette
Affiliation: Centre de Génétique Humaine, Centre Hospitalier Régional Universitaire, Université de Franche-Comté, Besançon, France.
Department of Neuromuscular Diseases UCL Queen Square Institute of Neurology, University College London, London, UK.
Department of Specialized Medicine, Division of Medical Genetics, McGill University Health Centre, Montreal, QC, Canada.
Laboratory of Medical Genetics, Translational Cytogenomics Research Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Department of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Department of Human Neurosciences, Institute of Child and Adolescent Neuropsychiatry, Sapienza University of Rome, Rome, Italy.
Division of Neuropsychiatry, Epilepsy Center for Children, Martini Hospital, 10141, Turin, Italy.
Service de Génétique Clinique, CHR d'Orléans, Orléans, France.
Unit of Neuromuscular and Neurodegenerative Disorders, Department of Neurosciences, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
Department of Pediatric Neurology, Developmental Medicine and Social Pediatrics, University of Munich, 80337, Munich, Germany.
Centre de Génétique Humaine, Centre Hospitalier Régional Universitaire, Université de Franche-Comté, Besançon, France.
UMR 1231 GAD, Inserm, Université de Bourgogne Franche Comté, Dijon, France.;Unité Fonctionnelle Innovation en Diagnostic Génomique des Maladies Rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.
Department of Medical Sciences, University of Torino, 10126, Turin, Italy.
Department of Pediatrics, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Centre de Génétique Humaine, Centre Hospitalier Régional Universitaire, Université de Franche-Comté, Besançon, France.
Department of Pediatrics, Division of Pediatric Neurology Saint-Luc University Hospital, and Institute of Neuroscience (IoNS), Catholic University of Louvain, Brussels, Belgium.
Department of Pediatrics, Division of Neonatology, University of California San Francisco, San Francisco, CA, USA.
Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Hôpital Arnaud de Villeneuve, CHU de Montpellier, Montpellier, France.
Division of Neonatology, Saint-Luc university Hospital, and Institut of Clinical and Experimental Research (IREC), Bruxelles, Belgium.
Aix Marseille Univ, INSERM, Marseille Medical Genetics Center, MMG, Marseille, France.
UMR 1231 GAD, Inserm, Université de Bourgogne Franche Comté, Dijon, France.;Unité Fonctionnelle Innovation en Diagnostic Génomique des Maladies Rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.
Medical Genetics Service and Laboratory of Cytogenetics, SIC Anatomia Patologica, "San Carlo" Hospital, 85100, Potenza, Italy.
CHU Reims, Service de Génétique, Reims, France.;CHU de Nantes, service de génétique médicale, Nantes, France.;L'institut du thorax, INSERM, UNIV Nantes, Nantes, France.
Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.
Clinical Genetics, Côte de Nacre University Hospital Center, Caen, France.
University of California San Diego, Department of Neurosciences, Rady Children's Institute for Genomic Medicine, San Diego, CA, 92037, USA.
Department of Genetics, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne University, Paris, France.
Service de neuropédiatrie, Centre Hospitalier Régional Universitaire, Université de Franche-Comté, Besançon, France.
Service de Médecine Génomique des Maladies Rares, Hôpital Necker Enfants Malades, Institut Imagine et Université Paris-Cité, Paris, France.
Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Department of Neuromuscular Diseases UCL Queen Square Institute of Neurology, University College London, London, UK.
Unit of Medical Genetics, IRCCS Instituto Giannina Gaslini, Genova, Italy.
Department of Neuromuscular Diseases UCL Queen Square Institute of Neurology, University College London, London, UK.
Genetic Services of Western Australia, King Edward Memorial Hospital, Perth, WA, 6008, Australia.
Department of Molecular Genetics, Next Generation Genetic Polyclinic, Mashhad, Iran.;Molecular and Clinical Sciences Institute, St. George's, University of London, Cranmer Terrace, London, SW17 0RE, UK.
Department of Neurology, Schneider Children's Medical Center of Israel, Petah Tiqva, Israel.;Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 6997801, Israel.
UMR 1231 GAD, Inserm, Université de Bourgogne Franche Comté, Dijon, France.;Oncobiologie Génétique Bioinformatique, PCBio, CHU Besançon, Besançon, France.
Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Institute for Pathology and Genetics, 6040, Gosselies, Belgium.
Division of Medical Genetics, Department of Pediatrics, Hasbro Children's Hospital, Providence, RI, USA.
APHP, Sorbonne Université, Département de Génétique, Paris, France.;Centre de Référence Déficiences Intellectuelles de Causes Rares, GH Pitié-Salpêtrière/Hôpital Armand Trousseau, Paris, France.
Clinical Genetics and Genomics, Royal Brompton and Harefield NHS Foundation Trust, London, UK.;NHLI, Imperial College London, London, UK.
Department of Neurology, Perth Children's Hospital, Nedlands, WA, Australia.;University of Western Australia, Nedlands, WA, Australia.
Service de Génétique Clinique, Centre Référence "Déficiences Intellectuelles de causes rares" (CRDI), Centre Référence Anomalies du développement (CLAD-Ouest), CHU Rennes, Univ Rennes, Rennes, France.
Service de Médecine Génomique des Maladies Rares, Hôpital Necker Enfants Malades, Institut Imagine et Université Paris-Cité, Paris, France.
Division of Genetics and Genomics and Howard Hughes Medical Institute, Boston Children's Hospital, Boston, MA, USA.
Service de Génétique Clinique, Centre Référence "Déficiences Intellectuelles de causes rares" (CRDI), Centre Référence Anomalies du développement (CLAD-Ouest), CHU Rennes, Univ Rennes, Rennes, France.
Department of Pediatrics, IWK Health Centre, Dalhousie University, Halifax, NS, Canada.
UMR 1231 GAD, Inserm, Université de Bourgogne Franche Comté, Dijon, France.;Unité Fonctionnelle Innovation en Diagnostic Génomique des Maladies Rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.
UOSD Neuro-oncology, IRCCS Giannina Gaslini, Genova, Italy.
Genetic Services of Western Australia, King Edward Memorial Hospital, Perth, WA, 6008, Australia.
Hospices Civils de Lyon, Service de Génétique, Bron, France.;Équipe GENDEV, Centre de Recherche en Neurosciences de Lyon, INSERM U1028 CNRS UMR5292, Université Claude Bernard Lyon 1, Lyon, France.
Service de Médecine Génomique des Maladies Rares, Hôpital Necker Enfants Malades, Institut Imagine et Université Paris-Cité, Paris, France.
Hôpital Femme Mère Enfant, Service de Neuropédiatrie, Bron, France.
Department of Neuromuscular Diseases UCL Queen Square Institute of Neurology, University College London, London, UK.;IRCCS Giannina Gaslini Institute, Genova, Italy.;Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Genova, Italy.
Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, VIC, Australia.;Royal Children's Hospital, Florey Institute and Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, VIC, Australia.
Department of Neurology, Boston Children's Hospital, Boston, MA, USA.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 6997801, Israel.
IRCCS Giannina Gaslini Institute, Genova, Italy.;Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Genova, Italy.
Department of Molecular Medicine, University of Pavia, Pavia, Italy.;Neurogenetics Research Center, IRCCS Mondino Foundation, Pavia, Italy.
Neonatal Intensive Care Unit, Institut Alix de Champagne, Reims, France.
Aix Marseille Univ, INSERM, Marseille Medical Genetics Center, MMG, Marseille, France.;Département de Génétique Médicale, AP-HM, Hôpital d'Enfants de La Timone, Marseille, France.
UMR 1231 GAD, Inserm, Université de Bourgogne Franche Comté, Dijon, France.;Unité Fonctionnelle Innovation en Diagnostic Génomique des Maladies Rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.
Department of Pediatric Neurology, Developmental Medicine and Social Pediatrics, University of Munich, 80337, Munich, Germany.
Department of Pediatric Neurology, Developmental Medicine and Social Pediatrics, University of Munich, 80337, Munich, Germany.;Institute for Neurogenomics, Helmholtz Center Munich, Neuherberg, Germany.;Institute of Human Genetics, School of Medicine, Technical University Munich, Munich, Germany.
Clinical Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt.
IRCCS Giannina Gaslini Institute, Genova, Italy.;Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Genova, Italy.
Hospices Civils de Lyon, Service de Génétique, Bron, France.;Pathophysiology and Genetics of Neuron and Muscle (PGNM, UCBL - CNRS UMR5261 - INSERM U1315), Université Claude Bernard Lyon 1, Lyon, France.
Genomic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Medical Genetics, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Genomic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Pediatrics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Medicine (University of Melbourne)
Department of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
Division of Genetics and Genomics and Howard Hughes Medical Institute, Boston Children's Hospital, Boston, MA, USA.
Laboratory of Medical Genetics, Translational Cytogenomics Research Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Department of Pediatric Neurology, Developmental Medicine and Social Pediatrics, University of Munich, 80337, Munich, Germany.
Astana Medical University, Nur-Sultan, Kazakhstan.
S. D. Asfendiyarov Kazakh National Medical University Almaty, Almaty, Kazakhstan.
Department of Neurology and Neurosurgery, Asfendiyarov Kazakh National Medical University, Almaty, 050000, Kazakhstan.
Department of Neurology, The International Institute of Postraduate Education, Almaty, Kazakhstan.
Unit of Medical Genetics, IRCCS Instituto Giannina Gaslini, Genova, Italy.
Department of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
Centre de Génétique Humaine, Centre Hospitalier Régional Universitaire, Université de Franche-Comté, Besançon, France.
Centre de Référence des Malformations et Maladies Congénitales du Cervelet, Département de Génétique, AP-HP, Sorbonne Université, Hôpital Trousseau, Paris, France.
Centre de Génétique Humaine, Centre Hospitalier Régional Universitaire, Université de Franche-Comté, Besançon, France.;UMR 1231 GAD, Inserm, Université de Bourgogne Franche Comté, Dijon, France.
Issue Date: Sep-2023
Date: 2023
Publication information: European Journal of Human Genetics : EJHG 2023-09; 31(9)
Abstract: BRAT1 biallelic variants are associated with rigidity and multifocal seizure syndrome, lethal neonatal (RMFSL), and neurodevelopmental disorder associating cerebellar atrophy with or without seizures syndrome (NEDCAS). To date, forty individuals have been reported in the literature. We collected clinical and molecular data from 57 additional cases allowing us to study a large cohort of 97 individuals and draw phenotype-genotype correlations. Fifty-nine individuals presented with BRAT1-related RMFSL phenotype. Most of them had no psychomotor acquisition (100%), epilepsy (100%), microcephaly (91%), limb rigidity (93%), and died prematurely (93%). Thirty-eight individuals presented a non-lethal phenotype of BRAT1-related NEDCAS phenotype. Seventy-six percent of the patients in this group were able to walk and 68% were able to say at least a few words. Most of them had cerebellar ataxia (82%), axial hypotonia (79%) and cerebellar atrophy (100%). Genotype-phenotype correlations in our cohort revealed that biallelic nonsense, frameshift or inframe deletion/insertion variants result in the severe BRAT1-related RMFSL phenotype (46/46; 100%). In contrast, genotypes with at least one missense were more likely associated with NEDCAS (28/34; 82%). The phenotype of patients carrying splice variants was variable: 41% presented with RMFSL (7/17) and 59% with NEDCAS (10/17).
URI: https://ahro.austin.org.au/austinjspui/handle/1/33190
DOI: 10.1038/s41431-023-01410-z
ORCID: 0000-0003-1531-7628
0000-0003-4530-4537
0000-0003-4158-341X
0000-0002-9102-6884
0000-0001-9276-4590
0000-0002-4816-1431
0000-0002-0526-465X
0000-0002-8318-7231
0000-0001-5233-0800
0000-0003-2652-362X
0000-0002-8986-8222
0000-0003-1007-1809
0000-0002-6713-8018
0000-0003-2610-0600
0000-0002-2866-7777
0000-0003-2814-6303
0000-0002-7780-4707
0000-0003-3985-1286
0000-0001-7098-6520
0000-0003-2815-6288
0000-0003-0132-7921
0000-0001-5260-7187
0000-0001-7008-1879
0000-0002-6065-1476
0000-0002-0600-6820
0000-0001-6657-5008
0000-0003-3717-8374
0000-0002-4454-8823
0000-0001-7840-0002
0000-0001-7691-9492
0000-0002-9996-9406
0000-0002-0156-2238
0000-0002-9037-4297
0000-0002-1119-6809
0000-0001-5244-5325
Journal: European Journal of Human Genetics : EJHG
PubMed URL: 37344571
ISSN: 1476-5438
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

50
checked on May 5, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.